News
AstraZeneca and Daiichi Sankyo are gunning to get Enhertu a new first-line approval in HER2-positive breast cancer after a ...
These therapies require primary T cells to be collected from the patient, be modified ex vivo, undergo expansion and quality ... s in vivo lentiviral-targeted delivery platform. Big pharma’s ...
Kailera jumped the weight loss miracle-drug line by licensing four clinical-stage obesity therapies from China, which is quickly emerging as a powerhouse pharmaceutical R&D center. After all ...
*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...
the former Saint Francis Ministries CEO who is charged with conspiracy to commit wire fraud, 15 counts of wire fraud, and one count of money laundering, asked the court last month to visit his ex ...
Federal prosecutor tells court ex-Saint Francis leader is a flight risk if he travels to El Salvador
Robert “Father Bobby” Smith, the former Saint Francis Ministries CEO who is charged with conspiracy to commit wire fraud, 15 counts of wire fraud, and one count of money laundering, asked the court ...
Former St Kilda and Adelaide midfielder Brad Crouch has named former Saints teammate Nasiah Wanganeen-Milera as a future "superstar" of the competition while also expecting the Crows to "come knocking ...
It suggests the Big Pharma gravy train is derailing, and its passengers in and out of government are panicking, prophesying and pulling out in a flurry of sky-is-falling predictions, ad hominem ...
Even though pharma imports from India into the US have been exempted from the levy of reciprocal tariffs by the US administration, caution and long-term measures are the need of the hour ...
Photo: Sarah Bridge The ‘yes’ campaign in the cruise referendum received a boost this week when Allen Chastanet, former prime minister of Saint Lucia, backed the call for the Cayman Islands to ...
Eton Pharmaceuticals (NASDAQ ... Per the terms, Barcelona-based Esteve will buy ex-U.S. rights for Increlex for up to ten years with an option to decide on buying the drug’s future international ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results